Rifampin for high blood calcium
Treatments studied
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if rifampin, a medicine usually used for infections, can lower high calcium levels in people with a rare genetic condition affecting vitamin D. It might help reduce symptoms like kidney stones or bone pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 months and 70 years old.
- You have a change in the CYP24A1 gene (confirmed by a genetic test).
- Your blood or urine calcium is above the normal range for your age.
- Your parathyroid hormone (PTH) level is lower than 20 pg/ml.
- You are not allergic to rifampin or similar medicines, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
This trial tests a new medication called PTH-IA for people with a specific genetic mutation affecting the parathyroid hormone receptor. The study aims to see if the medication is safe and can help improve bone health in children and adults with this rare condition.
This study tests whether giving a personalized dose of rifampin (a key TB medicine) can improve treatment. It is for people with active TB that is sensitive to rifampin, and it involves frequent blood and urine tests to measure drug levels.
This study tests a vitamin D-like medicine for people with a specific genetic cause of low active vitamin D (CYP24A1 deficiency). If you have the right gene change, it may help your body use vitamin D more normally.
This trial tests a medicine called encaleret in children with a rare genetic condition that causes low calcium levels. The goal is to see if it safely helps control calcium and reduce symptoms.
This study checks how your body handles a new medicine when it is taken with rifampicin, a common antibiotic. It helps researchers understand if the new medicine is safe and how it interacts with other drugs.
Hear when a new Genetic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.